Anebulo Pharmaceuticals I...

AI Score

0

Unlock

1.63
-0.01 (-0.61%)
At close: Jan 15, 2025, 12:59 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 3.09M 11.25M 14.55M 19.99M 3.02M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 565.12K n/a n/a n/a n/a
Receivables n/a n/a n/a n/a 3.50K
Inventory n/a n/a n/a n/a -3.5
Other Current Assets 413.79K 422.75K 1.03M 1.67M n/a
Total Current Assets 3.51M 11.25M 14.55M 19.99M 3.03M
Property-Plant & Equipment n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 565.12K n/a 1.03M 1.67M n/a
Total Assets 4.07M 11.67M 15.58M 21.65M 3.03M
Account Payables 156.43K 534.54K 380.83K 110.05K n/a
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a 201.29K
Other Current Liabilities 104.16K 534.26K 131.70K 131.59K 22.58K
Total Current Liabilities 260.58K 534.54K 512.53K 241.63K 223.87K
Long-Term Debt n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 534.26K 380.83K 131.59K 2.98M
Total Liabilities 260.58K 1.07M 512.53K 241.63K 3.20M
Total Debt n/a n/a n/a n/a 201.29K
Common Stock 25.93K 25.63K 23.34K 23.34K 12.00K
Retained Earnings -65.40M -57.20M -45.47M -38.64M -183.14K
Comprehensive Income n/a 0.00 n/a -21.65M -2.99M
Shareholders Equity 3.81M 10.60M 15.07M 21.41M -171.14K
Total Investments n/a n/a n/a n/a n/a